KBC Securities - Hyloris Pharmaceuticals (HYL) Morning Notes : HYL BB

Report

KBC Securities

Hilde Van Boxstael ...

Mathijs Geerts Danau
Wim Lewi

Morning Notes : HYL BB

: HYL BB

30/12/2025 1 EN

Underlying

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Mathijs Geerts Danau

Wim Lewi

Other Reports on these Companies

KBC Securities

Morning Notes : ARCAD NA, GIMB BB, HYL BB, CTPNV NA

: ARCAD NA, GIMB BB, HYL BB, CTPNV NA

January 20, 2026 January 20, 2026 1 EN

KBC Securities

Morning Notes : HYL BB

: HYL BB

December 31, 2025 December 31, 2025 1 EN

Morning Notes : AKZA NA, ELI BB, MELE BB, UCB BB, ONWD BB

: AKZA NA, ELI BB, MELE BB, UCB BB, ONWD BB

8h / 37m 8h / 37m 1 EN

Jacob Mekhael

Jacob Mekhael

UCB Presents supportive three-year Bimzelx data in HS at EHSF

UCB announced that three-year data from the BE HEARD trials for Bimzelx in moderate to severe HS will be presented at the Conference of the European Hidradenitis Suppurativa Foundation EHSF, being held 4–6 February in Malta. The data show high rates of total HS resolution at 3 years, high rates of improvement from moderate or severe HS to mild disease, as well as strong draining tunnel resolution. This continues to highlight Bimzelx' benefit in this patient group, which we believe will further drive commercial adoption of the drug – note that UCB upgraded its FY25 guidance in December 2025 bas...

8h / 51m 8h / 51m 1 EN

Guy Sips

Guy Sips

Melexis FIRST LOOK: Remaining in an uneven recovery

Melexis saw in 4Q25 still a challenging and unstable environment as the automotive industry demand continues to be cautious and choppy between quarters. They indicated they remain in an uneven recovery. Melexis highlighted that -looking at FY26- 1Q is traditionally impacted by annual customer pricing agreements and seasonal factors such as Chinese New Year and sales patterns outside of automotive. In addition, this year demand is affected by recent changes in EV automotive regulations and purchase incentive schemes. We lower our TP from € 74 to € 72 but maintain our Accumulate rating as we tak...

8h / 56m 8h / 56m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : HYL BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : ARCAD NA, GIMB BB, HYL BB, CTPNV NA

Morning Notes : HYL BB

Morning Notes : AKZA NA, ELI BB, MELE BB, UCB BB, ONWD BB

UCB Presents supportive three-year Bimzelx data in HS at EHSF

Melexis FIRST LOOK: Remaining in an uneven recovery

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe